News & Events News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Categorypress newsResearch news New findings pave the way for development of new therapies for incurable acute myeloid leukemia (AML) 5 Jun 2024 Deepening understanding of early mammalian embryogenesis 15 May 2024 Oncode Researchers Discover New Pathway to Cancer Cell Suicide 15 May 2024 Oncode Oncology Bridge Fund portfolio company Flindr Therapeutics announces €20 million Series A financing 26 Apr 2024 Flindr Therapeutics (previously Immagene) closes 20 million Series A financing 24 Apr 2024 Three Oncode Investigators awarded competitive ERC Advanced grant 10 Apr 2024 Bacteria in cancer unmasked 8 Apr 2024 Researchers discover a new transcription-coupled repair mechanism 3 Apr 2024 Beating by overheating: Oncode researchers lead study into new strategy to combat cancer 27 Mar 2024 Cinematography of Transcription: Real-time Tracking Software Reveals Relay Race on DNA 25 Mar 2024 New possibilities for improving cancer immunotherapy 18 Mar 2024 A New Tool for Understanding Protein Interactions at the Molecular Level 13 Mar 2024 Detection of specific DNA signature colon cancer is now improved 11 Mar 2024 Oncode Investigator Ton Schumacher selected to tackle one of the Cancer Grand Challenges 6 Mar 2024 First patients included in CPoC study towards less radical treatments for vulvar cancer 4 Mar 2024 Oncode Investigators Ruben van Boxtel, Puck Knipscheer and Jop Kind awarded prestigious NWO Vici grant 29 Feb 2024 Pagination Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›
New findings pave the way for development of new therapies for incurable acute myeloid leukemia (AML) 5 Jun 2024
Oncode Oncology Bridge Fund portfolio company Flindr Therapeutics announces €20 million Series A financing 26 Apr 2024
Oncode Investigators Ruben van Boxtel, Puck Knipscheer and Jop Kind awarded prestigious NWO Vici grant 29 Feb 2024
